Recently, Tata Motors updated its Nexon EV with a 45 kWh battery pack, starting at ₹13.99 lakh. We recently drove it in the city, shared our thoughts. However, it competes with the MG Windsor EV at ...

The board of directors of Tech Mahindra Ltd has recommended Final Dividend of Rs. 30/- per equity share of the face value of ...

Accelya Solutions India Limited has recorded consolidated operating income of Rs. 1,367.55 million for the quarter ended ...

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

Davidson County property values have jumped by an average of 45% since 2021 — unseating a record-high increase set just two reappraisal cycles ago. Davidson County Assessor of Property Vivian ...

In terms of IMAX results, the figures were impressive, with 45% of the weekend’s earnings coming from Premium Large Format (PLF) and IMAX. The film ranks among the top 10 all-time highest ...

Michael Badolato, 45, of Saybrook Street in Bulls Head, is scheduled to be sentenced April 29 by Judge Alexander B. Jeong in state Supreme Court, St. George, to 10 years in prison. “Badolato ...

J&J has said it will now need upfront payment in full for its anticoagulant Xarelto (rivaroxaban) and immunology therapy Stelara (ustekinumab), with a rebate paid later, rather than the previous ...

The Met Police attended alongside paramedics from the London Ambulance Service and London’s Air Ambulance, who treated a 45-year-old woman. But despite their best efforts, she was pronounced dead at ...

What's the most attractive stock right now in the medical technology space? We asked Seeking Alpha analyst Stephen Ayers for his pick. While its steady MedTech segment is vulnerable to economic ...

Bimekizumab – an IL-17A and IL-17F inhibitor – outdid both placebo and IL-12/IL-23 blocker Stelara (ustekinumab) when it came to clearing the skin of patients with moderate-to-severe chronic ...

J&J sues Samsung Bioepis over Stelara biosimilar Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to Stelara, J&J's blockbuster ...